Recognition of Research and Development Expenses
First written in FY2017-Q3. . Latest entry: FY2026.
92 other companies' latest entry also says "Other".
- FY2026Increase in annual R&D expensesAnnual report
「R&D expenses for the consolidated fiscal year were ¥1,149 million for the Group as a whole, comprising ¥840 million in Japan and ¥308 million in Asia by segment.」
Annual R&D expenses were ¥1,149 million, up from ¥1,026 million in the previous fiscal year. - FY2026-H1Updated to six-month R&D expensesAnnual report
「The total R&D expenses for the six-month cumulative consolidated period were ¥534 million.」
The actual R&D expenses were updated to ¥534 million for the six-month cumulative consolidated period. - FY2025Updated to annual R&D expensesAnnual report
「R&D expenses for the consolidated fiscal year were ¥1,026 million for the Group as a whole, comprising ¥770 million in Japan and ¥256 million in Asia by segment.」
Annual R&D expenses were ¥1,026 million, up from ¥893 million in the previous fiscal year. - FY2025-H1Updated to six-month R&D expensesAnnual report
「The total R&D expenses for the six-month cumulative consolidated period were ¥499 million.」
The actual R&D expenses were updated to ¥499 million for the six-month cumulative consolidated period. - FY2024Updated to annual R&D expensesAnnual report
「R&D expenses for the consolidated fiscal year were ¥893 million for the Group as a whole, comprising ¥652 million in Japan and ¥241 million in Asia by segment.」
Annual R&D expenses were updated to ¥893 million. This was up from ¥745 million in the previous fiscal year. - FY2024-Q3Updated to nine-month R&D expensesAnnual report
「The total R&D expenses for the nine-month cumulative consolidated period were ¥712 million.」
The actual R&D expenses were updated to ¥712 million for the nine-month cumulative consolidated period. - FY2024-Q2Updated to six-month R&D expensesAnnual report
「The total R&D expenses for the six-month cumulative consolidated period were ¥431 million.」
The actual R&D expenses were updated to ¥431 million for the six-month cumulative consolidated period. - FY2024-Q1Updated to quarterly R&D expensesAnnual report
「The total R&D expenses for the three-month cumulative consolidated period were ¥199 million.」
The actual R&D expenses were updated to ¥199 million for the three-month cumulative consolidated period. - FY2023-Q3Updated to nine-month R&D expensesAnnual report
「The total R&D expenses for the nine-month cumulative consolidated period were ¥570 million.」
The actual R&D expenses were updated to ¥570 million for the nine-month cumulative consolidated period. - FY2023-Q2Updated to six-month R&D expensesAnnual report
「The total R&D expenses for the six-month cumulative consolidated period were ¥346 million.」
The actual R&D expenses were updated to ¥346 million for the six-month cumulative consolidated period. - FY2023-Q1Updated to quarterly R&D expensesAnnual report
「The total R&D expenses for the three-month cumulative consolidated period were ¥168 million.」
The actual R&D expenses were updated to ¥168 million for the three-month cumulative consolidated period. - FY2022Updated to annual R&D expensesAnnual report
「R&D expenses for the consolidated fiscal year were ¥745 million for the Group as a whole, comprising ¥530 million in Japan and ¥214 million in Asia by segment.」
Annual R&D expenses were updated to ¥745 million. - FY2022-Q3Updated to nine-month R&D expensesAnnual report
「The total R&D expenses for the nine-month cumulative consolidated period were ¥545 million.」
The actual R&D expenses were updated to ¥545 million for the nine-month cumulative consolidated period. - FY2022-Q2Updated to six-month R&D expensesAnnual report
「The total R&D expenses for the six-month cumulative consolidated period were ¥355 million.」
The actual R&D expenses were updated to ¥355 million for the six-month cumulative consolidated period. - FY2022-Q1Updated to quarterly R&D expensesAnnual report
「The total R&D expenses for the three-month cumulative consolidated period were ¥158 million.」
The actual R&D expenses were updated to ¥158 million for the three-month cumulative consolidated period. - FY2021-Q3Updated to nine-month R&D expensesAnnual report
「The total R&D expenses for the nine-month cumulative consolidated period were ¥533 million.」
The actual R&D expenses were updated to ¥533 million for the nine-month cumulative consolidated period. - FY2021-Q2Updated to six-month R&D expensesAnnual report
「The total R&D expenses for the six-month cumulative consolidated period were ¥335 million.」
The actual R&D expenses were updated to ¥335 million for the six-month cumulative consolidated period. - FY2021-Q1Updated to quarterly R&D expensesAnnual report
「The total R&D expenses for the three-month cumulative consolidated period were ¥155 million.」
The actual R&D expenses were updated to ¥155 million for the three-month cumulative consolidated period. - FY2020Updated to annual R&D expensesAnnual report
「R&D expenses for the consolidated fiscal year were ¥723 million for the Group as a whole, comprising ¥503 million in Japan and ¥219 million in Asia by segment.」
Annual R&D expenses were updated to ¥723 million. - FY2020-Q3Updated to nine-month R&D expensesAnnual report
「The total R&D expenses for the nine-month cumulative consolidated period were ¥539 million.」
The actual R&D expenses were updated from ¥328 million for the six-month cumulative period to ¥539 million for the nine-month cumulative period. - FY2020-Q2Updated to six-month R&D expensesAnnual report
「The total R&D expenses for the six-month cumulative consolidated period were ¥328 million.」
The actual R&D expenses were updated to ¥328 million for the six-month cumulative consolidated period. - FY2020-Q1Updated to quarterly R&D expensesAnnual report
「The total R&D expenses for the three-month cumulative consolidated period were ¥152 million.」
The actual R&D expenses were updated to ¥152 million for the three-month cumulative consolidated period. - FY2019Updated to annual R&D expensesAnnual report
「R&D expenses for the consolidated fiscal year were ¥679 million for the Group as a whole, comprising ¥450 million in Japan and ¥229 million in Asia by segment.」
Annual R&D expenses were updated to ¥679 million. This was down from ¥734 million in the previous fiscal year. - FY2019-Q3Updated to nine-month R&D expensesAnnual report
「The total R&D expenses for the nine-month cumulative consolidated period were ¥503 million.」
The actual R&D expenses were updated to ¥503 million for the nine-month cumulative consolidated period. - FY2019-Q2Updated to six-month R&D expensesAnnual report
「The total R&D expenses for the six-month cumulative consolidated period were ¥304 million.」
The actual R&D expenses were updated to ¥304 million for the six-month cumulative consolidated period. - FY2019-Q1Updated to quarterly R&D expensesAnnual report
「The total R&D expenses for the three-month cumulative consolidated period were ¥151 million.」
The actual R&D expenses were updated to ¥151 million for the three-month cumulative consolidated period. - FY2018Updated to annual R&D expensesAnnual report
「R&D expenses for the consolidated fiscal year were ¥734 million for the Group as a whole, comprising ¥456 million in Japan and ¥277 million in Asia by segment.」
The actual R&D expenses were updated from ¥539 million in the previous fiscal year to ¥734 million in the current fiscal year. - FY2018-Q3Updated to nine-month R&D expensesAnnual report
「The total R&D expenses for the nine-month cumulative consolidated period were ¥528 million.」
The actual R&D expenses were updated to ¥528 million for the nine-month cumulative consolidated period. - FY2018-Q2Updated to six-month R&D expensesAnnual report
「The total R&D expenses for the six-month cumulative consolidated period were ¥285 million.」
The actual R&D expenses were updated to ¥285 million for the six-month cumulative consolidated period. - FY2018-Q1Updated to quarterly R&D expensesAnnual report
「The total R&D expenses for the three-month cumulative consolidated period were ¥117 million.」
The actual R&D expenses were updated to ¥117 million for the three-month cumulative consolidated period. - FY2017Updated to annual R&D expensesAnnual report
「R&D expenses for the consolidated fiscal year were ¥539 million for the Group as a whole, comprising ¥345 million in Japan and ¥193 million in Asia by segment.」
The actual R&D expenses were updated from ¥389 million for the nine-month cumulative period to ¥539 million for the full year. - FY2017-Q3First statedAnnual report
「The total R&D expenses for the nine-month cumulative consolidated period were ¥389 million.」
It states that total R&D expenses for the nine-month cumulative consolidated period were ¥389 million.